Controversial Dengue Drug Among Six Products To Get EMA Thumbs Up
Executive Summary
Dengvaxia, the dengue vaccine from Sanofi that was suspended in the Philippines last year, is among six new products to get a recommendation for marketing authorization from the European Medicines Agency this week.
You may also be interested in...
Anticancers, Orphans & The First CAR-Ts: New EU Drug Approvals In 2018
New approvals in the EU were again dominated by oncology drugs in 2018, although medicines for infectious diseases were a close second. The number of orphan drugs more than doubled over the previous year, to 17. There were also some star arrivals in multiple sclerosis, genetic disorders, metabolism and migraine.
EU New Drug Approvals 2018: Anticancers, Orphans, The First CAR-Ts – And More
New drug approvals in the EU were again dominated by oncology in 2018, although medicines for infectious diseases came a close second. The number of orphan drugs more than doubled over the previous year, to 17. There were also some key new arrivals in the areas of multiple sclerosis, genetic disorders, metabolism and migraine.
Latest Funding Moves Expand Keytruda Franchise In England
MSD's immunotherapy drug Keytruda is to be made available to thousands more patients with lung cancer or melanoma in England through the Cancer Drugs Fund.